9th Annual Advances in Neurology: Diagnosis and Practical Management of Patients with Nervous System Disorders

Saturday, October 29, 2022, 8:00 AM - 4:35 PM, 1470 Madison Avenue, The Leon and Norma Hess Center for Science and Medicine, Bonnie M. Davis, MD and Kenneth L. Davis, MD Auditorium, New York, NY


The 9th Annual Advances in Neurology is a full-day live CME event that will provide clinicians with an update on diagnostic processes, cutting-edge technologies, and innovative management strategies in these 8 areas of neurology: headache, movement disorders (including chemodenervation and deep brain stimulation), epilepsy, stroke, multiple sclerosis, neuromuscular disease, and neuro-oncology. Through didactic lecture, case presentations, and interactive discussions with expert clinicians, attendees will be better enabled to diagnose and manage patients living with neurologic disorders in 2022 and beyond. Patient simulators will interact with faculty to provide an enhanced learning experience for participants.

1. Discuss existing, new, and potential options for migraine treatment and prevention including oral medications, devices, injectables, and interventional therapies.
2. Summarize the guidelines and criteria for diagnosing and categorizing multiple sclerosis, and discuss a comprehensive management plan. .
3. Identify the symptoms of post-acute sequelae of COVID (PASC) to improve time to recognition and avoid unnecessary diagnostic testing.
4. Describe the options for acute stroke interventions required to obtain optimal neurological outcomes, and identify central retinal artery occlusion (CRAO) and branch retinal artery occlusion (BRAO).
5. Describe a strategic treatment plan for Parkinson disease (PD) that addresses the complex needs of patients as they progress thru the advancing stages of the disease, including the use of cannabis as a potential treatment option.
6. Describe novel diagnostic techniques and classification guidelines for primary brain tumors and brain metastases, and discuss targeted and biologic therapies including tumor treating fields medical device.
7. Explain strategies for diagnosing and treating epilepsy in children and adolescents, including surgical options.
8. Discuss the role of high-resolution neuromuscular ultrasound as a cost-effective and painless diagnostic tool for the evaluation of various focal and diffuse peripheral neuropathies.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, October 29, 2022